A mathematical model of breast and ovarian cancer treated with Paclitaxel

From MaRDI portal
Revision as of 16:14, 31 January 2024 by Import240129110113 (talk | contribs) (Created automatically from import240129110113)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Publication:1374118

DOI10.1016/S0025-5564(97)00077-1zbMath0893.92017WikidataQ52252206 ScholiaQ52252206MaRDI QIDQ1374118

John Carl Panetta

Publication date: 24 August 1998

Published in: Mathematical Biosciences (Search for Journal in Brave)




Related Items (max. 100)

Dynamics of a data based ovarian cancer growth and treatment model with time delayConstrained bilinear control problem: Application to a cancer chemotherapy modelA microenvironment based model of antimitotic therapy of Gompertzian tumor growthMathematical modeling of ovarian cancer treatments: sequencing of surgery and chemotherapyModelling chemistry and biology after implantation of a drug-eluting stent. II: Cell proliferationChemotherapy of vascularised tumours: role of vessel density and the effect of vascular ``pruningModelling the response of spatially structured tumours to chemotherapy: drug kineticsA mathematical model of in vitro cancer cell growth and treatment with the antimitotic agent curacin \(A\)Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemo\-therapyIntegrating cell-cycle progression, drug penetration and energy metabolism to identify improved cancer therapeutic strategiesTargeting the quiescent cells in cancer chemotherapy treatment: is it enough?Optimisation of Cancer Drug Treatments Using Cell Population DynamicsTumor Development Under Combination Treatments with Anti-angiogenic TherapiesMODELLING THE RESPONSE OF VASCULAR TUMOURS TO CHEMOTHERAPY: A MULTISCALE APPROACHA two-compartment model interacting with dynamic drugsA quasi birth-and-death model for tumor recurrenceMemory effects on the proliferative function in the cycle-specific of chemotherapyTwo-compartment model interacting with proliferating regulatory factor



Cites Work


This page was built for publication: A mathematical model of breast and ovarian cancer treated with Paclitaxel